Cerebrospinal Fluid Aβ to Tau Ratio and Postoperative Cognitive Change
Authors:
- 1 August 2013
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 258 (2) , 364-369
Abstract
Objective: Determination of biomarker and neuropathogenesis of postoperative cognitive change (POCC) or postoperative cognitive dysfunction. Background: POCC is one of the most common postoperative complications in elderly patients. Whether preoperative cerebrospinal fluid (CSF) β-amyloid protein (Aβ) to tau ratio, an Alzheimer disease biomarker, is a biomarker for risk of POCC remains unknown. We therefore set out to assess the association between preoperative CSF Aβ42 or Aβ40 to tau ratio and POCC. Methods: Patients who had total hip/knee replacement were enrolled. The CSF was obtained during the administration of spinal anesthesia. Cognitive tests were performed with these participants at 1 week before and at 1 week and 3 to 6 months after the surgery. Z scores of the changes from preoperative to postoperative on several key domains of the cognitive battery were determined. We then examined the association between preoperative CSF Aβ42/tau or Aβ40/tau ratio and the outcome measures described earlier, adjusting for age and sex. Results: Among the 136 participants (mean age = 71 ± 5 years; 55% men), preoperative CSF Aβ42/tau ratio was associated with postoperative Hopkins Verbal Learning Test Retention [Z score = 8.351; age, sex-adjusted (adj.) P = 0.003], and the Benton Judgment of Line Orientation (Z score = 1.242; adj. P = 0.007). Aβ40/tau ratio was associated with Brief Visuospatial Memory Test Total Recall (Z score = 1.045; adj. P = 0.044). Conclusions: Preoperative CSF Aβ/tau ratio is associated with postoperative changes in specific cognitive domains. The presence of the Alzheimer's disease biomarker, specifically the Aβ/tau ratio, may identify patients at higher risk for cognitive changes after surgery.Keywords
This publication has 42 references indexed in Scilit:
- CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findingsNeurology, 2012
- Elucidation of Primary Structure Elements Controlling Early Amyloid β-Protein OligomerizationJournal of Biological Chemistry, 2003
- Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer DiseaseJAMA, 2003
- Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathwaysProceedings of the National Academy of Sciences, 2002
- Alzheimer’s disease can be accurately diagnosed in very mildly impaired individualsNeurology, 2002
- Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neuronsJournal of Cell Biology, 2002
- Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer diseaseNeuroscience Letters, 2001
- Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass SurgeryNew England Journal of Medicine, 2001
- Preclinical prediction of AD using neuropsychological testsJournal of the International Neuropsychological Society, 2001
- Predicting Adverse Postoperative Outcomes in Patients Aged 80 Years or OlderJournal of the American Geriatrics Society, 2000